Publisher
Springer Science and Business Media LLC
Subject
Otorhinolaryngology,Surgery
Reference7 articles.
1. COVID-19-Associated Mucormycosis: Triple Threat of the Pandemic—American society for microbiology
2. Kumari A, Rao NP, Patnaik U et al (2021) Management outcomes of mucormycosis in COVID-19 patients: a preliminary report from a tertiary care hospital. Med J Armed Forces India 77(Suppl 2):S289–S295. https://doi.org/10.1016/j.mjafi.2021.06.009
3. Bellazreg F, Hattab Z, Meksi S et al (2014) Outcome of mucormycosis after treatment: report of five cases. New Microbes New Infect 6:49–52. https://doi.org/10.1016/j.nmni.2014.12.002
4. Nithyanandam S, Jacob MS, Battu RR, Thomas RK, Correa MA, DSouza O, (2003) Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol 51(3):231–236 (PMID: 14601848)
5. Ibrahim AS, Edwards JE Jr, Bryant R, Spellberg B (2009) Economic burden of mucormycosis in the United States: can a vaccine be cost-effective? Med Mycol 47(6):592–600. https://doi.org/10.1080/13693780802326001
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献